Malhi Harmeet, Barreyro Fernando J, Isomoto Hajime, Bronk Steven F, Gores Gregory J
Miles and Shirley Fiterman Center for Digestive Diseases, Mayo Clinic College of Medicine, Rochester, MN 55905, USA.
Gut. 2007 Aug;56(8):1124-31. doi: 10.1136/gut.2006.118059. Epub 2007 Apr 30.
Elevated circulating free fatty acids (FFA) contribute to the development of hepatic steatosis and promote hepatocyte apoptosis by incompletely defined mechanisms. Although the death ligand TRAIL has been implicated in a variety of pathological liver diseases, the role of TRAIL in mediating apoptosis of FFA induced steatotic hepatocytes is unknown.
We examined TRAIL cytotoxicity in an in vitro model of hepatocyte steatosis induced by FFA.
Hepatocytes (Huh 7 cells, HepG2 cells, and primary rat hepatocytes) were rendered steatotic by incubation with oleic acid. Apoptosis was assessed morphologically and biochemically by caspase activity. TRAIL receptor regulation was examined using immunoblot analysis and siRNA for targeted knockdown. c-jun N-terminal kinase (JNK) inhibition was attained with SP600125.
Oleic acid sensitised the cells to TRAIL but not TNF-alpha cytotoxicity. FFA sensitisation to TRAIL occurred at much lower concentrations than required for FFA mediated sensitisation to Fas, or FFA induced lipoapoptosis. Oleic acid treatment led to upregulation of the cognate TRAIL receptor death receptor 5 (DR5) but not death receptor 4 (DR4). The upregulation of DR5 was JNK dependent. siRNA targeted knockdown of either DR5 or DR4 demonstrated that DR5 was responsible for FFA sensitisation to TRAIL killing. DR5 expression was enhanced in steatotic human liver samples.
Our results suggest that FFA induced hepatocyte steatosis sensitises to TRAIL by a DR5 mediated JNK dependent mechanism.
循环游离脂肪酸(FFA)水平升高会导致肝脂肪变性,并通过不完全明确的机制促进肝细胞凋亡。尽管死亡配体TRAIL与多种病理性肝脏疾病有关,但TRAIL在介导FFA诱导的脂肪变性肝细胞凋亡中的作用尚不清楚。
我们在FFA诱导的肝细胞脂肪变性体外模型中检测了TRAIL的细胞毒性。
将肝细胞(Huh 7细胞、HepG2细胞和原代大鼠肝细胞)与油酸孵育使其发生脂肪变性。通过半胱天冬酶活性从形态学和生化方面评估细胞凋亡。使用免疫印迹分析和小干扰RNA(siRNA)靶向敲低来检测TRAIL受体调节情况。用SP600125抑制c-jun氨基末端激酶(JNK)。
油酸使细胞对TRAIL敏感,但对肿瘤坏死因子-α(TNF-α)细胞毒性不敏感。FFA对TRAIL的敏感性发生时的浓度远低于FFA介导的对Fas的敏感性或FFA诱导的脂质凋亡所需的浓度。油酸处理导致同源TRAIL受体死亡受体5(DR5)上调,但死亡受体4(DR4)未上调。DR5的上调依赖于JNK。对DR5或DR4进行siRNA靶向敲低表明,DR5是FFA对TRAIL杀伤敏感的原因。在脂肪变性的人肝脏样本中DR5表达增强。
我们的结果表明,FFA诱导的肝细胞脂肪变性通过DR5介导的JNK依赖机制使细胞对TRAIL敏感。